Mimedx (MDXG) EPS (Weighted Average and Diluted) Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -25,782.97% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.33% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.99% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.47% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -5.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.27% |
| Dec 31, 2025 | 12.62% |
| Sep 30, 2025 | 47.70% |
| Jun 30, 2025 | 36.54% |
| Mar 31, 2025 | 34.89% |
| Dec 31, 2024 | 65.10% |
| Sep 30, 2024 | 48.12% |
| Jun 30, 2024 | 81.71% |
| Mar 31, 2024 | 38.67% |
| Dec 31, 2023 | 61.04% |
| Sep 30, 2023 | 28.56% |
| Jun 30, 2023 | 28.56% |
| Mar 31, 2023 | -14.47% |
| Dec 31, 2022 | 44.22% |
| Sep 30, 2022 | -41.25% |
| Jun 30, 2022 | 11.74% |
| Mar 31, 2022 | 2.86% |
| Dec 31, 2021 | 61.11% |
| Sep 30, 2021 | -187.67% |
| Jun 30, 2021 | -51.83% |
| Mar 31, 2021 | -61.98% |
| Dec 31, 2020 | -84.20% |
| Sep 30, 2020 | -48.84% |
| Jun 30, 2020 | -42.42% |
| Mar 31, 2020 | -40.95% |
| Dec 31, 2019 | -50.37% |
| Sep 30, 2019 | 54.20% |
| Jun 30, 2019 | -115.44% |
| Mar 31, 2019 | -141.01% |
| Dec 31, 2018 | -72.03% |
| Sep 30, 2018 | -26.58% |
| Jun 30, 2018 | -26.32% |
| Mar 31, 2018 | 0.00% |
| Dec 31, 2017 | 10.06% |
| Sep 30, 2017 | 131.04% |
| Jun 30, 2017 | 197.60% |
| Mar 31, 2017 | 91.29% |
| Dec 31, 2016 | 91.29% |
| Sep 30, 2016 | 125.50% |
| Jun 30, 2016 | 58.74% |
| Mar 31, 2016 | 35.72% |
| Dec 31, 2015 | 135.13% |
| Sep 30, 2015 | 47.36% |
| Jun 30, 2015 | 91.29% |
| Mar 31, 2015 | 81.71% |